Chronic Opioid Use and Hypogonadism: Establishing a Dose-Response Relationship
This poster is part of a Virtual Poster Session, hosted by the Ochsner Continuing Medical Education. We encourage you to ask questions and engage in discussion on this poster! Authors will respond to comments between May 25- June 5, 2020.
Presenters
Natalie Hanks MD, Scott Rooney MD, Faeqeh Mir Yousefi Ata, Cruz Velasco PhD, Yashar Eshraghi MD, Maged Guirguis MD, Gabriel Uwaifo MD
Poster
(Click here to access this presentation as a PDF.)
These are some astounding though not unexpected results. I believe this confirms the notion that the combined approach of rehab, function, intervention, mindfulness and realistic goal setting are critical in this patient population to avoid potentially devastating comorbid issues.
Completely agreed.
Excellent presentation! What inspired your choice of the matching controls ratio of 1:4? Also since it was a retrospective case-control study, over what number of years was the study carried out and was this before or after the opioid Epidemic in the US? Finally was this study carried out in one medical center or in many medical centers? Thank you!
The data was analyzed from January 2012 to May 2019 and was gathered from the Ochsner Healthcare System. The matching ratio was based on the number of cases and controls and was up to a 1:4 ratio, so it included 1:2 and 1:3 as well. Thank you for your interest in the research!